Germany covid-19 Coronavirus Germany

Pfizer requests U.S. emergency use for its COVID-19 vaccine in kids aged 12-15

Reading now: 646
globalnews.ca

Pfizer and its German partner BioNTech said on Friday they have requested the U.S. Food and Drug Administration to expand the emergency use of their COVID-19 vaccine in adolescents aged 12 to 15.In March, the drugmakers said the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year olds in a clinical trial.

Pfizer says COVID-19 vaccine is 100% effective in protecting kids aged 12-15 in trial Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer.

Inoculating children and young people is considered a critical step toward reaching “herd immunity” and taming the pandemic, according to experts.The companies plan to request similar.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA